A 52-year-old woman with a 10-year history of seropositive rheumatoid arthritis (RF and anti-CCP positive) presents with progressive joint destruction despite conventional DMARD therapy. Synovial biopsy shows hyperplastic synovium with abundant macrophages, activated fibroblasts, and neovascularization. All of the following pathological findings are consistent with RA synovitis EXCEPT:

Explanation

## Pathological Features of RA Synovitis ### Synovial Inflammation Architecture **Key Point:** RA synovitis is characterized by a hyperplastic, inflammatory synovium with distinct cellular zones: an outer lining layer rich in macrophages and fibroblasts, a middle layer with lymphocyte infiltration, and a pannus at the bone–cartilage interface driving erosion. ### Cytokine-Driven Inflammation **High-Yield:** TNF-α and IL-6 are the dominant pro-inflammatory cytokines in RA synovitis: - TNF-α: produced by macrophages and synovial fibroblasts; activates endothelial cells, promotes leukocyte recruitment, and induces IL-6 production - IL-6: amplifies B cell and T cell activation; drives acute phase response (CRP, ESR) - Both are targets of biologic DMARD therapy (anti-TNF agents, IL-6 receptor antagonists) **Clinical Pearl:** TNF-α inhibitors (infliximab, etanercept, adalimumab) are among the most effective therapies for RA because they suppress both local synovial inflammation and systemic immune activation. ### Osteoclast Activation and Bone Erosion **Key Point:** Bone erosion in RA is driven by osteoclasts activated at the pannus–bone interface: - RANKL (receptor activator of nuclear factor κB ligand) is expressed by activated T cells and synovial fibroblasts - M-CSF (macrophage colony-stimulating factor) provides survival and differentiation signals to osteoclast precursors - Osteoclasts resorb bone directly, creating the characteristic marginal erosions seen on X-ray **Mnemonic:** **RANKL-M-CSF axis** = Bone loss in RA. RANKL is the key signal; M-CSF is the permissive factor. ### Neutrophil Extracellular Traps (NETs) **Key Point:** Neutrophils are abundant in RA synovial fluid and contribute to tissue damage via NETs: - NETs are web-like structures of decondensed chromatin, histones, and granular proteins released by activated neutrophils - NET-associated proteases (elastase, cathepsin G) and antimicrobial peptides (LL-37) damage synovial tissue - NETs also contain citrullinated proteins, which are targets of anti-CCP antibodies, perpetuating the autoimmune response **Clinical Pearl:** High synovial fluid neutrophil counts (>2000 cells/µL) are typical of active RA and correlate with disease activity. ### Immune Complex Composition — The Distractor **Warning:** The incorrect option claims "IgA immune complexes" with "exclusive activation of the lectin pathway." This is FALSE on two counts: 1. **Immunoglobulin Class:** Immune complexes in RA synovium are predominantly **IgG and IgM**, not IgA: - IgG and IgM form the bulk of circulating and tissue-deposited immune complexes in RA - IgA-dominant immune complexes are characteristic of IgA vasculitis (formerly IgA nephropathy), NOT RA - IgA vasculitis primarily affects small vessels in skin and kidneys, not synovium 2. **Complement Pathway:** RA immune complexes activate complement via **classical and alternative pathways**, not exclusively lectin pathway: - **Classical pathway:** IgG and IgM in immune complexes bind C1q directly (the primary pathway in RA) - **Alternative pathway:** Amplification loop is activated secondarily - **Lectin pathway:** Activated by mannose-binding lectin (MBL) binding to pathogen-associated molecular patterns; NOT the dominant pathway in RA immune complex disease 3. **Consequence:** Complement activation generates C3a and C5a, which recruit neutrophils and macrophages, amplifying synovial inflammation. ### Comparison Table: Immune Complex Diseases | Disease | Dominant Immunoglobulin | Primary Complement Pathway | Tissue Affected | |---|---|---|---| | Rheumatoid Arthritis | IgG, IgM | Classical (via C1q) | Synovium, systemic vasculitis | | IgA Vasculitis | IgA | Lectin (via MBL) | Skin, kidney, GI tract | | SLE | IgG | Classical (via C1q) | Kidney (lupus nephritis), skin, joints | | Post-infectious GN | IgG, IgM | Classical (via C1q) | Kidney | ### Summary of Correct Statements - **Option 1 (TRUE):** TNF-α and IL-6 are the hallmark cytokines in RA synovitis, driving both local and systemic inflammation. - **Option 2 (TRUE):** Osteoclast precursors and activated osteoclasts at the pannus–bone interface are essential to bone erosion, mediated by RANKL and M-CSF. - **Option 3 (TRUE):** Neutrophil infiltration and NET formation are prominent features of RA synovitis; NETs contain proteases and citrullinated antigens. - **Option 4 (FALSE):** Immune complexes in RA are IgG/IgM-dominant (not IgA) and activate complement via classical pathway (not exclusively lectin pathway).